GIUNCHEDI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 21.739
AS - Asia 10.490
EU - Europa 7.033
SA - Sud America 5.968
Continente sconosciuto - Info sul continente non disponibili 356
AF - Africa 321
OC - Oceania 39
AN - Antartide 1
Totale 45.947
Nazione #
US - Stati Uniti d'America 21.234
BR - Brasile 5.282
SG - Singapore 4.111
CN - Cina 3.274
UA - Ucraina 2.245
IT - Italia 1.329
HK - Hong Kong 977
DE - Germania 867
VN - Vietnam 775
SE - Svezia 743
FR - Francia 579
FI - Finlandia 421
GB - Regno Unito 288
AR - Argentina 248
TR - Turchia 217
CA - Canada 198
IN - India 181
BD - Bangladesh 127
IQ - Iraq 127
MX - Messico 120
EC - Ecuador 114
RU - Federazione Russa 111
VE - Venezuela 106
ZA - Sudafrica 87
PK - Pakistan 83
UZ - Uzbekistan 81
JP - Giappone 70
CO - Colombia 68
MA - Marocco 65
KR - Corea 58
CZ - Repubblica Ceca 53
PL - Polonia 52
ES - Italia 45
NL - Olanda 45
PY - Paraguay 45
ID - Indonesia 38
JO - Giordania 38
BE - Belgio 35
PE - Perù 35
AT - Austria 34
CL - Cile 34
DZ - Algeria 34
AU - Australia 33
AZ - Azerbaigian 33
EG - Egitto 32
KE - Kenya 32
TN - Tunisia 30
LT - Lituania 29
AE - Emirati Arabi Uniti 28
CR - Costa Rica 27
HN - Honduras 27
SA - Arabia Saudita 25
IR - Iran 24
JM - Giamaica 24
KZ - Kazakistan 22
UY - Uruguay 22
DO - Repubblica Dominicana 21
EU - Europa 21
NP - Nepal 21
OM - Oman 20
PH - Filippine 20
BY - Bielorussia 17
RO - Romania 17
IL - Israele 16
KG - Kirghizistan 16
NI - Nicaragua 16
TT - Trinidad e Tobago 15
AL - Albania 14
MY - Malesia 14
PA - Panama 14
AO - Angola 13
GT - Guatemala 12
BG - Bulgaria 11
BN - Brunei Darussalam 11
GE - Georgia 11
IE - Irlanda 11
SN - Senegal 11
BO - Bolivia 10
CH - Svizzera 10
LB - Libano 9
PR - Porto Rico 9
PS - Palestinian Territory 9
SV - El Salvador 9
AM - Armenia 8
GR - Grecia 8
RS - Serbia 8
SY - Repubblica araba siriana 8
CW - ???statistics.table.value.countryCode.CW??? 7
TH - Thailandia 7
BH - Bahrain 6
DK - Danimarca 6
HR - Croazia 6
HU - Ungheria 6
QA - Qatar 6
EE - Estonia 5
LU - Lussemburgo 5
MD - Moldavia 5
MN - Mongolia 5
SI - Slovenia 5
BZ - Belize 4
Totale 45.545
Città #
Dallas 6.445
Singapore 2.108
Chandler 1.932
San Jose 1.697
Jacksonville 1.346
Ashburn 1.227
Hong Kong 954
Council Bluffs 776
Princeton 735
Nanjing 581
Beijing 536
Santa Clara 528
Columbus 445
São Paulo 387
New York 366
Lauterbourg 352
Wilmington 295
Dearborn 293
Ho Chi Minh City 271
Boardman 256
Milan 218
Los Angeles 216
Sassari 211
Nanchang 208
Shanghai 188
Hanoi 179
Rio de Janeiro 159
Belo Horizonte 150
Tianjin 146
Shenyang 140
Ann Arbor 120
Changsha 114
Hebei 113
Jiaxing 102
Brasília 99
Woodbridge 81
Curitiba 78
Porto Alegre 76
Miano 75
Helsinki 73
Tashkent 72
Baghdad 67
San Francisco 67
Andover 66
Tokyo 65
Jinan 64
Toronto 64
Buffalo 62
Salvador 61
Orem 60
Norwalk 59
Rome 58
Chennai 54
Chicago 54
Seoul 53
The Dalles 53
Kunming 52
Munich 51
Campinas 50
Hangzhou 50
Izmir 47
Ningbo 45
Buenos Aires 44
Istanbul 44
Mountain View 44
Brooklyn 43
Warsaw 42
Haiphong 41
Johannesburg 41
Atlanta 40
Montreal 40
Brno 39
Fortaleza 39
Quito 39
Goiânia 38
London 38
Da Nang 37
Denver 37
Guayaquil 37
Santo André 37
Romola 36
Zhengzhou 36
Guarulhos 35
Naples 35
Phoenix 35
Amman 33
Houston 33
Brussels 32
Frankfurt am Main 32
Juiz de Fora 32
Osasco 32
Baku 31
Ribeirão Preto 30
Volta Redonda 29
Manaus 28
Recife 28
Taizhou 28
Amsterdam 27
Mauá 27
Mexico City 27
Totale 26.896
Nome #
Hyaluronic acid: Development and application in drug delivery systems. 315
Nasal Administration of Hyaluronic Acid-Based Hybrid Nanoparticles Loaded with Dimethyl Fumarate. 265
Hyaluronic acid based-hybrid nanoparticles for targeted nose-to-brain delivery of dimethyl fumarate. 252
Aqueous injection of quercetin: an approach for confirmation of its direct in vivo cardiovascular effects 245
A new diffusion system for the evaluation of transmucosal permeation across synthetic or biological membranes 234
Hybrid Nanoparticles for Intranasal delivery of Dimethyl Fumarate. 232
A new sensitive reversed phase high-performance liquid chromatography method for the quantitative determination of metoclopramide in canine plasma 228
A pharmacokinetic study on thymol-β-cyclodextrin complex. 222
Impact of hyaluronic acid molecular weight on silibinin intranasal delivery via hybrid nanoparticle formulation 220
Silibinin-loaded amphiphilic nanoparticles: A promising drug delivery system for lung cancer therapy. 217
Antagonistic activities of natural zeolite against Helicobacter pylori infection 216
Rutin-loaded nasal hybrid nanoparticles: assessing potential protection from anthracycline-induced brain endothelial damage. 215
A new sensitive reversed phase HPLC method for the quantitative determination of metoclopramide in canine plasma 215
Hyaluronic acid-based hybrid nanoparticles for intranasal delivery of dimethyl fumarate 215
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 204
Gastrointestinal controlled release of Rose Bengal from its Chitosan Salt embedded in alginate matrix. 201
Celle di permeazione 201
La silibinina incapsulata in nanoparticelle mostra aumentata citotossicità rispetto alla molecola libera in cellule di carcinoma polmonare. 199
Green Routes for Bio-Fabrication in Biomedical and Pharmaceutical Applications 198
Development of solid nanoparticles based on Hydroxypropyl-beta-cyclodextrin aimed for the colonic transmucosal delivery of Diclofenac sodium 198
Alginate polymeric film containing propolis: characterisation and in vitro permeation behaviour 194
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 193
Silibinin-loaded amphiphilic nanoparticles as an efficient drug delivery system for lung cancer therapy. 192
A new apparatus for the evaluation of polymer adhesive properties 191
Evaluation of alginate compressed matrices as prolonged drug delivery systems 191
Artichoke extract as penetration enhancer in topical gel formulation: in-vitro and in-vivo studies 188
A new Ibuprofen pulsed release oral dosage form 187
Encapsulation and modified-release of thymol from oral microparticles as adjuvant or substitute to current medications 186
Administration of drug loaded chitosan microparticles and brain uptake 185
Natural zeolites for pharmaceutical formulations: Preparation and evaluation of a clinoptilolite-based material 184
Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of Ketoprofen 183
Controlled release hydrogel produced by frontal polymerization for veterinary use 181
Intranasal delivery of genistein-loaded nanoparticles as a potential preventive system against neurodegenerative disorders 177
A swellable polymer as Carbamazepine dissolution rate enhancer 176
Bilayer-tablets based on poly (ε−caprolactone) and polymethylmethacrilates as controlled release systems for ruminants, 176
Antiviral activities of 5-chlorobenzotriazole derivatives 173
Transmucosal Solid Lipid Nanoparticles to Improve Genistein Absorption Via Intestinal Lymphatic Transport 173
A new approach for the pH-independent release of basic drugs 173
A calorimetric study on diflunisal release from poly(lactide-co-glycolide) microspheres by monitoring the drug effect on dipalmitoylphosphatidylcholine liposomes. Temperature and drug loading influence 172
A Ketoprofen "multiple units" oral formulation exhibiting pulsatile in-vivo plasma levels 171
Spray-dried PDLLA microspheres containing Carboplatin for veterinary use: in vitro and in vivo studies 170
Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery 170
Bioactive dosage forms for the healing of skin and mucosa lesions: development of lipidic microplatforms (LM) based on propolis 170
Biodegradable microspheres as intravitreal delivery systems for the prolonged drug release. What is their actually in the nanoparticle era? 170
Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels 169
Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres 168
A water-soluble preparation for intravenous administration of isorhamnetin and its pharmacokinetics in rats 167
Nanotechnology-based rose Bengal: A broad-spectrum biomedical tool 167
A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery 166
A new pulsed release oral dosage form 166
ALGINATE AND CHITOSAN MICROSPHERES FOR NASAL ADMINISTRATION OF CARBAMAZEPINE 161
Development of natural zeolite-based systems as drug carriers to be used against gastric infections caused by Helicobacter pylori 161
A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate 161
Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management 160
Alginate microparticles containing probiotic bacteria and polyphenolic extracts as new nutraceutical preparations 160
DEVELOPMENT OF SULPHUR-SALICYLIC GEL SYSTEMS AS NEW BIOACTIVE FORMULATIONS FOR THE TOPICAL TREATMENT OF ACNE VULGARIS 158
) Diflunisal release from PLGA microspheres loaded with different amount of drug. A kinetic study by DSC 157
Chitosan microspheres as carrier of an antiamoebic drug: Rokitamycin 156
A new Ibuprofen pulsed release oral dosage form. 154
Prolonged skin retention of clobetasol propionate by bio-based microemulsions: a potential tool for scalp psoriasis treatment 153
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 152
9th Pharmaceutical Technology Conference 152
Alginate mucoadhesive microspheres as nasal controlled release systems for brain targeting of dopamine 152
Hydroxypropyl-β-cyclodextrin formulated in nasal chitosan microspheres as candidate therapeutic agent in Alzheimer's disease 150
Evaluation of Manuka honey as an adjuvant antimicrobial preservative in a O/W emulsion 148
Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy 148
Biodegradabile controlled release tablets 147
EXPLOITING CLINOPTILOLITE AGAINST HELICOBACTER PYLORI: POSSIBILITY OR UTOPIA? 146
Deferoxamine Mesilate For The Treatment Of Stroke: A Formulative Study On Nasal Microspheres 146
Spray-dried microspheres containing ketoprofen formulated into capsules and tablets 144
Increasing protective activity of genistein by loading into transfersomes: A new potential adjuvant in the oxidative stress-related neurodegenerative diseases? 144
A new production technology for a Pulsatile Delivery Device 143
Indocyanine Green Loaded Polymeric Nanoparticles: Physicochemical Characterization and Interaction Studies with Caco-2 Cell Line by Light and Transmission Electron Microscopy 141
Design and evaluation of dry-coated tablets for colonic delivery of diclofenac sodium 141
Development of nasal formulations for a hydrophilic iron chelator, deferoxamine, useful in neurodegenerative disorders 141
Composite chitosan/alginate hydrogel for controlled release of deferoxamine: a system to potentially treat iron dysregulation diseases 141
Albumin microspheres for ocular delivery of Piroxicam 140
Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles 139
Propolis as lipid bioactive nano-carrier for topical nasal drug delivery 139
Mucoadhesive microspheres for nasal administration of Cyclodextrins 139
Lymph node metastases: importance of detection and treatment strategies 137
Solid microparticles based on chitosan or methyl-β-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 136
In situ forming poly(ε-caprolactone) microspheres for transarterial embolization therapy 135
Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds 134
Frontal polymerization as a new method for developing drug controlled release systems (DCRS) based on polyacrylamide 134
In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies 134
Solid lipid nanoparticles: an interesting approach for oral delivery of Genistein 134
Hyaluronic Acid-Based Hybrid Nanoparticles as Promising Carriers for the Intranasal Administration of Dimethyl Fumarate 133
Biodegradable controlled release tablets,– 133
Preparation, in-vitro characterization and preliminary in-vivo evaluation of buccal polymeric films containing Chlorhexidine 133
Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms 132
In-vitro evaluation of alginate compressed matrices as sustained drug delivery systems. 131
Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study 131
The effect of formulative parameters on the size and physical stability of SLN based on “green” components 130
Microcapsules containing seminal material for artificial insemination in pigs. 129
Modification of the dissolution behaviour of Naftazone for linear release matrix preparation. 129
Tabletted polylactide microspheres prepared by a w/o emulsion spray-drying method 128
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 128
Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting 127
Study Of The Influence Of Spray-Drying Parameters On The Preparation And Stability Of Eudragit®-Ketoprofen Microspheres 126
Totale 16.929
Categoria #
all - tutte 181.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.375 0 0 0 18 17 12 77 136 133 81 188 713
2022/20233.846 389 134 45 612 483 654 3 485 687 26 193 135
2023/20241.131 194 74 25 30 159 249 57 51 1 24 74 193
2024/202510.544 116 68 615 174 398 312 806 2.175 3.855 1.359 368 298
2025/202615.939 578 3.581 3.655 2.070 1.104 880 2.122 464 584 560 270 71
2026/20274.464 295 1.084 1.406 1.679 0 0 0 0 0 0 0 0
Totale 45.947